Dyne Therapeutics Inc DYN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/03/24 EDT
26.08UNCH (UNCH)
Volume
18,591
Close
26.08quote price arrow up+0.08 (+0.31%)
Volume
743,132
52 week range
6.40 - 30.27
Loading...
  • Open26.00
  • Day High27.31
  • Day Low25.87
  • Prev Close26.00
  • 52 Week High30.27
  • 52 Week High Date03/01/24
  • 52 Week Low6.40
  • 52 Week Low Date10/30/23

Key Stats

  • Market Cap2.248B
  • Shares Out86.18M
  • 10 Day Average Volume0.82M
  • Dividend-
  • Dividend Yield-
  • Beta1.00
  • YTD % Change96.09

KEY STATS

  • Open26.00
  • Day High27.31
  • Day Low25.87
  • Prev Close26.00
  • 52 Week High30.27
  • 52 Week High Date03/01/24
  • 52 Week Low6.40
  • 52 Week Low Date10/30/23
  • Market Cap2.248B
  • Shares Out86.18M
  • 10 Day Average Volume0.82M
  • Dividend-
  • Dividend Yield-
  • Beta1.00
  • YTD % Change96.09

RATIOS/PROFITABILITY

  • EPS (TTM)-3.94
  • P/E (TTM)-6.62
  • Fwd P/E (NTM)-8.01
  • EBITDA (TTM)-240.487M
  • ROE (TTM)-137.31%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/01/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Dyne Therapeutics Inc

Profile

MORE
Dyne Therapeutics Inc. is a clinical-stage muscle disease company. It is focused on advancing life-transforming therapeutics for people living with genetically driven diseases. It is utilizing its FORCE platform to overcome the limitations of muscle tissue delivery and oligonucleotide therapeutics for muscle diseases. Its FORCE platform therapeutics consist of an oligonucleotide payload that is designed to target the genetic basis of the disease. Using its FORCE platform, it...
Jason Rhodes
Independent Chairman of the Board
John Cox
President, Chief Executive Officer, Director
Susanna High
Chief Operating Officer
Address
1560 Trapelo Road
Waltham, MA
02451
United States

Top Peers

SYMBOLLASTCHG%CHG
KROS
Keros Therapeutics Inc
60.57+3.47+6.08%
CLDX
Celldex Therapeutics Inc
42.56+1.70+4.16%
KURA
Kura Oncology Inc
20.63+0.04+0.19%
GERN
Geron Corp
3.93-0.02-0.51%
RCKT
Rocket Pharmaceuticals Inc
23.47+0.70+3.07%